Bavarian Nordic AS (CHIX:BAVAC) Marketable Securities: kr1,599 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
79 GF Score
Price kr188.30
GF Value kr164.93
! 3 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Marketable Securities?

Bavarian Nordic AS CHIX:BAVAC 79 Marketable Securities is kr1,599 Mil as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 79/100 and a GF Value™ of kr164.93. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bavarian Nordic AS's Marketable Securities for the quarter that ended in Mar. 2026 was kr1,599 Mil.

Bavarian Nordic AS's annual Marketable Securities increased from Dec. 2023 (kr390 Mil) to Dec. 2024 (kr552 Mil) and increased from Dec. 2024 (kr552 Mil) to Dec. 2025 (kr1,619 Mil).

Bavarian Nordic AS  (CHIX:BAVAc) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Bavarian Nordic AS Marketable Securities Related Terms

Bavarian Nordic AS Marketable Securities Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS Marketable Securities Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,124.80 2,269.76 390.25 551.54 1,619.00

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 544.35 442.44 884.94 1,619.00 1,599.45
CHIX:BAVAC
79GF Score
Bavarian Nordic AS CHIX:BAVAC
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of kr1,599 Mil mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Marketable Securities of kr1,599 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Marketable Securities too high?
Bavarian Nordic AS's current Marketable Securities is kr1,599 Mil. Overall, Bavarian Nordic AS has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Marketable Securities compare to VRTX and REGN?
Bavarian Nordic AS's Marketable Securities of kr1,599 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Marketable Securities is kr1,599 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Bavarian Nordic AS (CHIX:BAVAC) has a current Marketable Securities of kr1,599 Mil. The stock's GF Value™ is kr164.93, compared to a current price of kr188.30 — trading 14.2% above its estimated fair value. The current Marketable Securities is kr1,599 Mil. Bavarian Nordic AS's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Marketable Securities is kr1,599 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 14.2% above its estimated GF Value™ of kr164.93.

Key valuation signals for CHIX:BAVAC:

  • Marketable Securities: kr1,599 Mil
  • GF Value™: kr164.93 vs. price of kr188.30 (14.2% above fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
79GF Score

Get the complete analysis for CHIX:BAVAC

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr164.93
GF Value